Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981903892> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2981903892 abstract "Abstract Background Although European guideline recommends that statin should be given to all patients with acute myocardial infarction (AMI), irrespective of cholesterol concentration, limited studies were focused on the long-term effects of statin therapy between ST-segment elevation MI (STEMI) and non-ST-segment elevation MI (NSTEMI). Purpose The authors conducted the study to compare the relative beneficial role of statin on 2-year major clinical outcomes between STEMI and NSTEMI in patients who underwent successful PCI with DES. Methods Finally, a total of 26317 AMI patients who underwent stent implantation and who were prescribed the statin were enrolled and they were separated into two groups; the STEMI group (n=15002) and the NSTEMI group (n=11315). The clinical endpoint was the occurrence of major adverse cardiac events (MACE) defined as all-cause death, recurrent myocardial infarction (re-MI), total coronary revascularization (target lesion revascularization [TLR], target vessel revascularization [TVR], non-TVR) during 2-year follow-up period. Results After propensity score-matched (PSM) analysis, two PSM groups (7746 pairs, n=15492, C-statistic = 0.766) were generated. In the total study population, the cumulative incidences of MACE, all-cause death, and cardiac death were significantly higher in the NSTEMI group. However, after PSM, the cumulative incidence of all-cause death (Hazard ratio, 1.386; 95% CI, 1.133–1.696; p=0.002) was significantly higher in the NSTEMI group. The cumulative incidences of MACE, cardiac death, re-MI, total revascularization, TLR, TVR, and non-TVR were similar between the two groups (Table 1). Outcomes Cumulative Events at 2-year (%) Hazard Ratio (95% CI) p value STEMI NSTEMI Log-rank Propensity score matched patients MACE 532 (7.2) 584 (8.1) 0.092 1.106 (0.984–1.244) 0.092 All-cause death 163 (2.2) 224 (3.1) 0.001 1.386 (1.133–1.696) 0.002 Cardiac death 121 (1.5) 148 (2.0) 0.088 1.232 (0.969–1.566) 0.089 Re-MI 117 (1.6) 107 (1.5) 0.545 0.922 (0.710–1.199) 0.545 Total revascularization 291 (4.1) 307 (4.4) 0.422 1.068 (0.910–1.254) 0.423 TLR 92 (1.3) 89 (1.2) 0.880 0.978 (0.731–1.309) 0.880 TVR 173 (2.4) 184 (2.6) 0.478 1.078 (0.876–1.327) 0.478 Non-TVR 123 (1.7) 130 (1.9) 0.593 1.070 (0.836–1.369) 0.539 Conclusion The mortality reduction capability of statin was more prominent in the STEMI group compared with the NSTEMI group." @default.
- W2981903892 created "2019-11-01" @default.
- W2981903892 creator A5003896875 @default.
- W2981903892 creator A5008942832 @default.
- W2981903892 creator A5012362413 @default.
- W2981903892 creator A5021505514 @default.
- W2981903892 creator A5038631110 @default.
- W2981903892 creator A5038931011 @default.
- W2981903892 creator A5044417303 @default.
- W2981903892 creator A5051332182 @default.
- W2981903892 creator A5053575162 @default.
- W2981903892 creator A5064935577 @default.
- W2981903892 creator A5066668223 @default.
- W2981903892 creator A5067971106 @default.
- W2981903892 creator A5077421037 @default.
- W2981903892 date "2019-10-01" @default.
- W2981903892 modified "2023-10-17" @default.
- W2981903892 title "P5362Impact of statin therapy on long-term clinical outcomes between STEMI and NSTEMI after stent implantation" @default.
- W2981903892 doi "https://doi.org/10.1093/eurheartj/ehz746.0327" @default.
- W2981903892 hasPublicationYear "2019" @default.
- W2981903892 type Work @default.
- W2981903892 sameAs 2981903892 @default.
- W2981903892 citedByCount "0" @default.
- W2981903892 crossrefType "journal-article" @default.
- W2981903892 hasAuthorship W2981903892A5003896875 @default.
- W2981903892 hasAuthorship W2981903892A5008942832 @default.
- W2981903892 hasAuthorship W2981903892A5012362413 @default.
- W2981903892 hasAuthorship W2981903892A5021505514 @default.
- W2981903892 hasAuthorship W2981903892A5038631110 @default.
- W2981903892 hasAuthorship W2981903892A5038931011 @default.
- W2981903892 hasAuthorship W2981903892A5044417303 @default.
- W2981903892 hasAuthorship W2981903892A5051332182 @default.
- W2981903892 hasAuthorship W2981903892A5053575162 @default.
- W2981903892 hasAuthorship W2981903892A5064935577 @default.
- W2981903892 hasAuthorship W2981903892A5066668223 @default.
- W2981903892 hasAuthorship W2981903892A5067971106 @default.
- W2981903892 hasAuthorship W2981903892A5077421037 @default.
- W2981903892 hasConcept C121332964 @default.
- W2981903892 hasConcept C126322002 @default.
- W2981903892 hasConcept C164705383 @default.
- W2981903892 hasConcept C2776839432 @default.
- W2981903892 hasConcept C2778583881 @default.
- W2981903892 hasConcept C61797465 @default.
- W2981903892 hasConcept C62520636 @default.
- W2981903892 hasConcept C71924100 @default.
- W2981903892 hasConceptScore W2981903892C121332964 @default.
- W2981903892 hasConceptScore W2981903892C126322002 @default.
- W2981903892 hasConceptScore W2981903892C164705383 @default.
- W2981903892 hasConceptScore W2981903892C2776839432 @default.
- W2981903892 hasConceptScore W2981903892C2778583881 @default.
- W2981903892 hasConceptScore W2981903892C61797465 @default.
- W2981903892 hasConceptScore W2981903892C62520636 @default.
- W2981903892 hasConceptScore W2981903892C71924100 @default.
- W2981903892 hasLocation W29819038921 @default.
- W2981903892 hasOpenAccess W2981903892 @default.
- W2981903892 hasPrimaryLocation W29819038921 @default.
- W2981903892 isParatext "false" @default.
- W2981903892 isRetracted "false" @default.
- W2981903892 magId "2981903892" @default.
- W2981903892 workType "article" @default.